BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

bluebird bio 

840 Memorial Drive

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-491-5601 Fax: 617-576-2421


SEARCH JOBS


Industry
Biotechnology

Segment
Gene Therapy





 Company News
bluebird bio Announces First Patient Transplanted In Phase 1/2 Northstar Study For The Treatment Of Beta-Thalassemia 3/27/2014 9:11:00 AM    More...
bluebird bio Reports Fiscal Year End 2013 Financial Results 3/6/2014 7:21:25 AM    More...
bluebird bio To Present At The Cowen and Company Health Care Conference 2/27/2014 7:15:40 AM    More...
bluebird bio To Present At The Leerink Swann and Company Global Healthcare Conference 2/6/2014 6:54:31 AM    More...
bluebird bio Appoints Dr James Mandell To Its Board Of Directors 1/9/2014 7:05:40 AM    More...
bluebird bio Announces First Patient Transplanted In Phase 1/2 HGB-205 Study For The Treatment Of Beta-Thalassemia And Sickle Cell Anemia 12/2/2013 9:15:14 AM    More...
bluebird bio To Present At Deutsche Bank (DB) BioFEST Conference 11/27/2013 7:07:17 AM    More...
bluebird bio Reports Fiscal Third Quarter 2013 Financial Results 11/15/2013 10:04:32 AM    More...
bluebird bio Announces First Patient Transplanted in Phase 2/3 Starbeam ALD-102 Study for the Treatment of CCALD 10/28/2013 10:21:58 AM    More...
bluebird bio Joins the Russell 2000® Index 10/2/2013 11:06:21 AM    More...
1234

//-->